• The Emerging Role Of Pharmacists In Clinical Research

    Clinical Research News | The role pharmacists play in the community is the same one they should be playing in clinical research, according to Gerald Finken, founder and CEO of RxE2 whose mission it is to help make that happen. His belief is that “community-based clinical trials” in general can be better for patient care, the pharmacy as a profession, and study sponsors who have long had trouble recruiting enough patients into their studies.

    Jan 27, 2022

  • Looking Forward to EU Regulation (EU) No 536/2014

    Clinical Research News | The EU Clinical Trials Register will be implemented on 31 January 2022, with the launch of the harmonized Clinical Trials Information System (CTIS) in all EU and EEA Member States. It is one of the most fundamental changes in the regulatory landscape for clinical trials in Europe. It is both historic and exciting.

    Jan 26, 2022

  • Canadian Brain Institute Opens Data Sharing on Alzheimer’s, Parkinson’s, More

    Clinical Research News | After a decade of methodical preparation, Canada’s Ontario Brain Institute's (OBI) neuroinformatics platform, Brain-CODE, launched its open data sharing feature for global brain disorder research.

    Jan 25, 2022

  • Logistical Challenges Of The ‘Reverse Supply Chain’ For Biospecimens

    Clinical Research News | The pandemic has served to highlight shortcomings of traditional practices around the cold-chain transport of biospecimens for clinical trials—including no backup plans when airports, borders, and study sites unexpectedly close. Even in normal times, default choices such as contracting mostly if not exclusively with premium couriers, can “artificially increase the cost of clinical trial conduct,” in the view of Thomas McDonald, associate director of biospecimen logistics for Bristol Myers Squibb Co. (BMS).

    Jan 24, 2022

  • Where AI Can Add Efficiencies To Clinical Trials

    Clinical Research News | Acceptance of artificial intelligence (AI) in clinical research is on the rise thanks, in part, to its pairing with human expert oversight. The result is faster, more efficient clinical trials with less of the bias associated with purely manual evaluations while sidestepping the potential risks of AI.

    Jan 20, 2022